28416/34351US=61 / Câncer
Rak JW, Coomber B, Yu JL. Physiological resistance: oncogenes and tumor suppressor genes in therapeutic resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 67-103. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

ONCOGENES; GENES SUPRESSORES DE TUMORES; RESISTENCIA AS DROGAS; MICROAMBIENTE; INTERACOES TUMOR-HOSPEDEIRO

28417/34351US=61 / Câncer
Mankoff DA, Krohn KA. Physiological resistance: PET imaging of response and resistance to cancer therapy. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 105-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

CANCER DE IMAGENS; PET; RESPOSTA; RESISTENCIA; IMAGIOLOGIA MOLECULAR

28418/34351US=61 / Câncer
Mantle I, Dontu G, Liu S, Wicha MS. Biological resistance: cancer stem cells. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 125-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

QUIMIOTERAPIA CITOTOXICA; DESREGULACAO; HETEROGENEIDADE TUMOR; TUMOR DE CELULAS ESTAMINAIS; MODELO DE TUMOR DE CELULAS-TRONCO

28419/34351US=61 / Câncer
Waud WR. Biological resistance: therapeutic resistance in leukemia. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 137-50. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

LEUCEMIA P388; LINHAS TUMORAIS RESISTENTES A DROGAS; RESISTENCIA AS DROGAS; RESISTENCIA TERAPEUTICA

28420/34351US=61 / Câncer
Arjona AA, Alvarez E. Biological resistance: tumor site implantation and animal model selection in oncology. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 151-9. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

LOCAL DO TUMOR; IMPLANTACAO SUBCUTANEA; TUMORES INTRADERMICOS; ANGIOGENESE; HIPOXIA

28421/34351US=61 / Câncer
Teicher BA. Biological resistance: in vivo resistance. In: ___. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 161-79. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

RESISTENCIA A CISPLATINA; RESISTENCIA CICLOFOSFAMIDA; EMT-6 CARCINOMA MAMARIO; RESISTENCIA IN VIVO; FATOR DE CRESCIMENTO TRANSFORMANTE-B

28422/34351US=61 / Câncer
Melnikova VO, Bar-Eli M. Biological resistance: characteristics of the metastatic phenotype. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 181-200. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

MELANOMA; METASTASE; ANGIOGENESE; REGULACAO TRANSCRICIONAL; AP-2; CREB

28423/34351US=61 / Câncer
Morin PJ. Biological resistance: the microenvironment and drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 201-10. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

MICROAMBIENTE; MATRIZ EXTRACELULAR; CITOCINAS; FACTORES DE CRESCIMENTO; RESISTENCIA AS DROGAS; APOPTOSE; ANOIKIS

28424/34351US=61 / Câncer
Findlay VJ, Townsed DM, Tew KD. Biochemical resistance: glutathione S-transferases in drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 213-21. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

GLUTATIONA; GLUTATIONA-S-TRANSFERASE; RESISTENCIA AS DROGAS; CANCER; MAPK; CAMINHO

28425/34351US=61 / Câncer
Notta F, Koropatnick DJ. Biochemical resistance: metallothioneins in drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 223-39. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

METALOTIONEINAS; GLUTATIONA; CISPLATINA; VARREDORES DE RADICAIS LIVRES; SULFIDRILOS PROTEINA

28426/34351US=61 / Câncer
Monti E. Biochemical resistance: molecular determinants of intrinsic multidrug resistance in cancer cells and tumors. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 241-60. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

APOPTOSE; RESISTENCIA INTRINSECA; LRP; MRP; P-GLICOPROTEINA

28427/34351US=61 / Câncer
Bates SE, Deeken J, Fan C, Robey RW. Biochemical resistance: new and revised concepts in multidrug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 261-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

MULTIRRESISTENCIA; SNPS; GP170; SETAMIBI; MULTIRRESISTENCIA; DERIVAM DE CELULAS

28428/34351US=61 / Câncer
Siddik ZH. Biochemical resistance: cisplatin resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 283-307. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

CISPLATINA; RESISTENCIA; MECANISMO MOLECULAR; ADUTOS DE DNA; RECONHECIMENTO DE DANOS; DNA DE TOLERANCIA AO DANO; CICLO CELULAR; APOPTOSE

28429/34351US=61 / Câncer
Safaei R, Howell SB. Biochemical resistance: regulation of the cellular pharmacology and cytotoxicity of cisplatin by copper transporters. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 309-27. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

CISPLATINA; COBRE; COBRE TRANSPORTADORES METALICOS COMPLEXOS METALLOTRANS PORTEIROS

28430/34351US=61 / Câncer
Greenberger LM, Sampath D. Biochemical resistance: resistance to taxanes. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 329-58. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

TAXANOS; RESISTENCIA; MICROTUBULOS; TUBULIN; TRANSPORTADORES; P-GLICOPROTEINA; APOPTOSE; TRANSDUCAO DE SINAL

28431/34351US=61 / Câncer
Teodoridis JM, Brown R. Biochemical resistance: CpG island methylation and drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 359-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

METILACAO; EPIGENETICA; DNMT; HISTONAS; ILHAS CPG

28432/34351US=61 / Câncer
Hazlehurst LA, Dalton WS. Biochemical resistance: de novo and acquired resistance to antitumor alkylating agents. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 377-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

AGENTES ALQUILANTES ANTITUMORAIS; DE NOVO A RESISTENCIA; RESISTENCIA ADQUIRIDA; GLUTATIONA; GLUTATIONA-S-TRANSFERASE; FANCONI ANEMIA/BRCA1 CAMINHO

28433/34351US=61 / Câncer
Sledge Junior GW, Miller KD, Schneider B, Sweeney CJ. Biochemical resistance: resistance to to antiangiogenic agents. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 391-410. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

ANTIANGIOGENESIS; FACTORES DE CRESCIMENTO ENDOTELIAIS VASCULARES; RECEPTOR DO FATOR ENDOTELIAL VASCULAR; HIPOXIA; INIBIDORES DA TIROSINA QUINASE

28434/34351US=61 / Câncer
osipo C, O'Regan RM. The role of hormones, growth factors, and oncogenes: resistance to antiestrogens. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 411-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

ANTIESTROGENEO; RESISTENCIA; TAMOXIFEN; CANCER DE MAMA; RECEPTOR DE ESTROGENO; INIBIDORES DE AROMATASE; FACTORES DE CRESCIMENTO

28435/34351US=8 / Anestesia
Rebuglio R, Amaral JLG, Slikta Filho J. Intubação traqueal. In: Cangiani LM, Posso IP, Potério GMB, Nogueira CS. Tratado de anestesiologia SAESP. 6ª ed. São Paulo: Atheneu, 2006. p. 1059-97. ISBN 85-7379-866-1.

INTUBACAO TRAQUEAL; LARINGE; TRAQUEIA; LARINGOSCOPIO DE BULLARD; LARINGOSCOPIO DE MCCOY; LARINGOSCOPIO ARTICULADO; LARINGOSCOPIO DE VIEWMAX; TUBOS TRAQUEAIS; TECNICA DE INTUBACAO TRAQUEAL; TUBO TRAQUEAL

Primeira | Anterior | Próxima | Última